Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | ONO-4685 |
| Synonyms | |
| Therapy Description |
ONO-4685 is a bispecific antibody that targets PDCD1 (PD-1) and CD3, which has potential anti-tumor activity (NCI Drug Dictionary). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| ONO-4685 | ONO4685|ONO 4685 | CD3 Antibody 119 PD-L1/PD-1 antibody 132 | ONO-4685 is a bispecific antibody that targets PDCD1 (PD-1) and CD3, which has potential anti-tumor activity (NCI Drug Dictionary). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT05079282 | Phase I | ONO-4685 | Study of ONO-4685 in Patients With Relapsed or Refractory T Cell Lymphoma | Recruiting | USA | 0 |